Skip to main content
Top
Published in: Breast Cancer 4/2008

01-10-2008 | Original Article

Surgical treatment for chest wall invasion due to the local recurrence of breast cancer

Authors: Takeshi Hanagiri, Tadahiro Nozoe, Takashi Yoshimatsu, Makiko Mizukami, Yoshinobu Ichiki, Masakazu Sugaya, Manabu Yasuda, Mitsuhiro Takenoyama, Kenji Sugio, Hiroshi Yasuda, Kosei Yasumoto

Published in: Breast Cancer | Issue 4/2008

Login to get access

Abstract

Objective

In this study, we investigated the surgical results for chest wall invasion of local recurrence of breast cancer.

Patients and methods

We reviewed eight patients who underwent a chest wall resection for local recurrence of breast cancer in our department between 1986 and 2004.

Results

All of the patients had local recurrence without any distant metastasis. All of them had skin ulcers with blood oozing. The operation procedures were Bt + Ax + Ic + Mj + Mn (Halsted mastectomy) in four patients, Bt + Ax + Ic + Mn (Patey procedure) in two patients, Bt + Ax + Ic (muscle-preserving mastectomy) in one patient, and Bt + Ax (Auchincloss procedure) in one patient. The intervals from the primary operation ranged from 14 months to 20 years. The maximum and minimum areas of the chest wall defect were 18×16 cm and 4.5×3.5 cm, respectively. Reconstruction of the chest wall was performed using a flap of the rectus abdominis muscle with polypropylene (Marlex®) mesh in four patients, a flap of the rectus abdominis muscle combined with sandwich prosthesis of polypropylene mesh and methylmethacrylate in one patient, a flap of latissimus dorsi muscle in one patient, polypropylene mesh with pectoralis major muscle in one patient, and by direct closure in one patient. A survivial of more than 3 years was achieved in seven patients and only one patient died 1 year and 2 months after the chest wall resection.

Conclusion

In patients with the chest wall recurrence of breast cancer without distant metastasis, a surgical resection of the chest wall may be effective both for relieving pain and for control of the local hemorrhage. Seven out of the eight patients survived more than 3 years, suggesting that this surgical treatment could facilitate home health care and maintain a good quality of life for patients with breast cancer.
Literature
1.
go back to reference Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74–108.PubMedCrossRef Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74–108.PubMedCrossRef
2.
go back to reference Elder EE, Kennedy CW, Gluch L, Carmalt HL, Janu NC, Joseph MG, Donellan MJ, Molland JG, Gillett DJ. Patterns of breast cancer relapse. Eur J Surg Oncol. 2006;32:922–7.PubMedCrossRef Elder EE, Kennedy CW, Gluch L, Carmalt HL, Janu NC, Joseph MG, Donellan MJ, Molland JG, Gillett DJ. Patterns of breast cancer relapse. Eur J Surg Oncol. 2006;32:922–7.PubMedCrossRef
3.
go back to reference Hiramanek N. Breast cancer recurrence: follow-up after treatment for primary breast cancer. Postgrad Med J. 2004;80:172–6.PubMedCrossRef Hiramanek N. Breast cancer recurrence: follow-up after treatment for primary breast cancer. Postgrad Med J. 2004;80:172–6.PubMedCrossRef
4.
go back to reference Buzdar AU. Phase III study of letrozole versus tamoxifen as first-line therapy of advanced breast cancer in postmenopausal women: analysis of survival and update of efficacy from the international letrozole breast cancer group. J Clin Oncol. 2004;22:3199–200.PubMedCrossRef Buzdar AU. Phase III study of letrozole versus tamoxifen as first-line therapy of advanced breast cancer in postmenopausal women: analysis of survival and update of efficacy from the international letrozole breast cancer group. J Clin Oncol. 2004;22:3199–200.PubMedCrossRef
5.
go back to reference Robertson JF, Come SE, Jones SE, Beex L, Kaufmann M, Makris A, Nortier JW, Possinger K, Rutqvist LE. Endocrine treatment options for advanced breast cancer—the role of fulvestrant. Eur J Cancer. 2005;41:346–56.PubMedCrossRef Robertson JF, Come SE, Jones SE, Beex L, Kaufmann M, Makris A, Nortier JW, Possinger K, Rutqvist LE. Endocrine treatment options for advanced breast cancer—the role of fulvestrant. Eur J Cancer. 2005;41:346–56.PubMedCrossRef
6.
go back to reference Sledge GW, Neuberg D, Bernardo P, Ingle JN, Martino S, Rowinsky EK, Wood WC. Phase III trial of doxorubicin, paclitaxel, and the combination of doxorubicin and paclitaxel as front-line chemotherapy for metastatic breast cancer: an intergroup trial. J Clin Oncol. 2003;21:588–92.PubMedCrossRef Sledge GW, Neuberg D, Bernardo P, Ingle JN, Martino S, Rowinsky EK, Wood WC. Phase III trial of doxorubicin, paclitaxel, and the combination of doxorubicin and paclitaxel as front-line chemotherapy for metastatic breast cancer: an intergroup trial. J Clin Oncol. 2003;21:588–92.PubMedCrossRef
7.
go back to reference Buchanan CL, Dorn PL, Fey J, Giron G, Naik A, Mendez J, Murphy C, Sclafani LM. Locoregional recurrence after mastectomy: incidence and outcomes. J Am Coll Surg. 2006;203:469–74.PubMedCrossRef Buchanan CL, Dorn PL, Fey J, Giron G, Naik A, Mendez J, Murphy C, Sclafani LM. Locoregional recurrence after mastectomy: incidence and outcomes. J Am Coll Surg. 2006;203:469–74.PubMedCrossRef
8.
go back to reference Jagsi R, Raad RA, Goldberg S, Sullivan T, Michaelson J, Powell SN, Taghian AG. Locoregional recurrence rates and prognostic factors for failure in node-negative patients treated with mastectomy: implications for postmastectomy radiation. Int J Radiat Oncol Biol Phys. 2005;62:1035–9.PubMed Jagsi R, Raad RA, Goldberg S, Sullivan T, Michaelson J, Powell SN, Taghian AG. Locoregional recurrence rates and prognostic factors for failure in node-negative patients treated with mastectomy: implications for postmastectomy radiation. Int J Radiat Oncol Biol Phys. 2005;62:1035–9.PubMed
9.
go back to reference Chagpar A, Meric-Bernstam F, Hunt KK, Ross MI, Cristofanilli M, Singletary SE, Buchholz TA, Ames FC, Marcy S, Babiera GV, Feig BW, Hortobagyi GN, Kuerer HM. Chest wall recurrence after mastectomy does not always portend a dismal outcome. Ann Surg Oncol. 2003;10:628–34.PubMedCrossRef Chagpar A, Meric-Bernstam F, Hunt KK, Ross MI, Cristofanilli M, Singletary SE, Buchholz TA, Ames FC, Marcy S, Babiera GV, Feig BW, Hortobagyi GN, Kuerer HM. Chest wall recurrence after mastectomy does not always portend a dismal outcome. Ann Surg Oncol. 2003;10:628–34.PubMedCrossRef
10.
go back to reference Willner J, Kiricuta IC, Kolbl O. Locoregional recurrence of breast cancer following mastectomy: always a fatal event? Results of univariate and multivariate analysis. Int J Radiat Oncol Biol Phys. 1997;37:853–63.PubMed Willner J, Kiricuta IC, Kolbl O. Locoregional recurrence of breast cancer following mastectomy: always a fatal event? Results of univariate and multivariate analysis. Int J Radiat Oncol Biol Phys. 1997;37:853–63.PubMed
11.
go back to reference Brower ST, Weinberg H, Tartter PI, Camunas J. Chest wall resection for locally recurrent breast cancer: indications, technique, and results. J Surg Oncol. 1992;49:189–95.PubMedCrossRef Brower ST, Weinberg H, Tartter PI, Camunas J. Chest wall resection for locally recurrent breast cancer: indications, technique, and results. J Surg Oncol. 1992;49:189–95.PubMedCrossRef
12.
go back to reference Miyauchi K, Koyama H, Noguchi S, Inaji H, Yamamoto H, Kodama K, Iwanaga T. Surgical treatment for chest wall recurrence of breast cancer. Eur J Cancer. 1992;28A:1059–62.PubMedCrossRef Miyauchi K, Koyama H, Noguchi S, Inaji H, Yamamoto H, Kodama K, Iwanaga T. Surgical treatment for chest wall recurrence of breast cancer. Eur J Cancer. 1992;28A:1059–62.PubMedCrossRef
13.
go back to reference Toi M, Tanaka S, Bando M, Hayashi K, Tominaga T. Outcome of surgical resection for chest wall recurrence in breast cancer patients. J Surg Oncol. 1997;64:23–6.PubMedCrossRef Toi M, Tanaka S, Bando M, Hayashi K, Tominaga T. Outcome of surgical resection for chest wall recurrence in breast cancer patients. J Surg Oncol. 1997;64:23–6.PubMedCrossRef
14.
go back to reference Leonard RC, Rodger A, Dixon JM. ABC of breast diseases. Metastas breast cancer BMJ. 1994;309:1501–4. Leonard RC, Rodger A, Dixon JM. ABC of breast diseases. Metastas breast cancer BMJ. 1994;309:1501–4.
15.
go back to reference Imkampe A, Bendall S, Bates T. The significance of the site of recurrence to subsequent breast cancer survival. Eur J Surg Oncol. 2007;33:420–3.PubMedCrossRef Imkampe A, Bendall S, Bates T. The significance of the site of recurrence to subsequent breast cancer survival. Eur J Surg Oncol. 2007;33:420–3.PubMedCrossRef
16.
go back to reference Nabholtz JM, Buzdar A, Pollak M, Harwin W, Burton G, Mangalik A, Steinberg M, Webster A, von Euler M. Anastrozole is superior to tamoxifen as first-line therapy for advanced breast cancer in postmenopausal women: results of a North American multicenter randomized trial. Arimidex Study Group. J Clin Oncol. 2000;18:3758–67.PubMed Nabholtz JM, Buzdar A, Pollak M, Harwin W, Burton G, Mangalik A, Steinberg M, Webster A, von Euler M. Anastrozole is superior to tamoxifen as first-line therapy for advanced breast cancer in postmenopausal women: results of a North American multicenter randomized trial. Arimidex Study Group. J Clin Oncol. 2000;18:3758–67.PubMed
17.
go back to reference Schwaibold F, Fowble BL, Solin LJ, Schultz DJ, Goodman RL. The results of radiation therapy for isolated local regional recurrence after mastectomy. Int J Radiat Oncol Biol Phys. 1991;21:299–310.PubMed Schwaibold F, Fowble BL, Solin LJ, Schultz DJ, Goodman RL. The results of radiation therapy for isolated local regional recurrence after mastectomy. Int J Radiat Oncol Biol Phys. 1991;21:299–310.PubMed
18.
go back to reference Haylock BJ, Coppin CM, Jackson J, Basco VE, Wilson KS. Locoregional first recurrence after mastectomy: prospective cohort studies with and without immediate chemotherapy. Int J Radiat Oncol Biol Phys. 2000;46:355–62.PubMedCrossRef Haylock BJ, Coppin CM, Jackson J, Basco VE, Wilson KS. Locoregional first recurrence after mastectomy: prospective cohort studies with and without immediate chemotherapy. Int J Radiat Oncol Biol Phys. 2000;46:355–62.PubMedCrossRef
19.
go back to reference Borner M, Bacchi M, Goldhirsch A, Greiner R, Harder F, Castiglione M, Jungi WF, Thurlimann B, Cavalli F, Obrecht JP, et al. First isolated locoregional recurrence following mastectomy for breast cancer: results of a phase III multicenter study comparing systemic treatment with observation after excision and radiation. Swiss Group for Clinical Cancer Research. J Clin Oncol. 1994;12:2071–7.PubMed Borner M, Bacchi M, Goldhirsch A, Greiner R, Harder F, Castiglione M, Jungi WF, Thurlimann B, Cavalli F, Obrecht JP, et al. First isolated locoregional recurrence following mastectomy for breast cancer: results of a phase III multicenter study comparing systemic treatment with observation after excision and radiation. Swiss Group for Clinical Cancer Research. J Clin Oncol. 1994;12:2071–7.PubMed
20.
go back to reference Serletti JM. Breast reconstruction with the TRAM flap: pedicled and free. J Surg Oncol. 2006;94:532–7.PubMedCrossRef Serletti JM. Breast reconstruction with the TRAM flap: pedicled and free. J Surg Oncol. 2006;94:532–7.PubMedCrossRef
21.
go back to reference Freeman ME, Perdikis G, Sternberg EG, TerKonda SP, Waldorf JC. Latissimus dorsi reconstruction: a good option for patients with failed breast conservation therapy. Ann Plast Surg. 2006;57:134–7.PubMedCrossRef Freeman ME, Perdikis G, Sternberg EG, TerKonda SP, Waldorf JC. Latissimus dorsi reconstruction: a good option for patients with failed breast conservation therapy. Ann Plast Surg. 2006;57:134–7.PubMedCrossRef
22.
go back to reference Akan M, Eker Ulucay G, Kargi B, Yildirim S, Akoz T. Combined reconstruction of complex defects of the chest wall. Scand J Plast Reconstr Surg Hand Surg. 2006;40:93–100.PubMedCrossRef Akan M, Eker Ulucay G, Kargi B, Yildirim S, Akoz T. Combined reconstruction of complex defects of the chest wall. Scand J Plast Reconstr Surg Hand Surg. 2006;40:93–100.PubMedCrossRef
23.
go back to reference Howard MA, Polo K, Pusic AL, Cordeiro PG, Hidalgo DA, Mehrara B, Disa JJ. Breast cancer local recurrence after mastectomy and TRAM flap reconstruction: incidence and treatment options. Plast Reconstr Surg. 2006;117:1381–6.PubMedCrossRef Howard MA, Polo K, Pusic AL, Cordeiro PG, Hidalgo DA, Mehrara B, Disa JJ. Breast cancer local recurrence after mastectomy and TRAM flap reconstruction: incidence and treatment options. Plast Reconstr Surg. 2006;117:1381–6.PubMedCrossRef
24.
go back to reference Snoj M, Arnez ZM, Sadikov A, Suvorov N. Breast reconstruction following mastectomy for invasive breast cancer by free flaps from the abdomen is oncologically safe. Eur J Surg Oncol. 2007;33:541–5.PubMedCrossRef Snoj M, Arnez ZM, Sadikov A, Suvorov N. Breast reconstruction following mastectomy for invasive breast cancer by free flaps from the abdomen is oncologically safe. Eur J Surg Oncol. 2007;33:541–5.PubMedCrossRef
Metadata
Title
Surgical treatment for chest wall invasion due to the local recurrence of breast cancer
Authors
Takeshi Hanagiri
Tadahiro Nozoe
Takashi Yoshimatsu
Makiko Mizukami
Yoshinobu Ichiki
Masakazu Sugaya
Manabu Yasuda
Mitsuhiro Takenoyama
Kenji Sugio
Hiroshi Yasuda
Kosei Yasumoto
Publication date
01-10-2008
Publisher
Springer Japan
Published in
Breast Cancer / Issue 4/2008
Print ISSN: 1340-6868
Electronic ISSN: 1880-4233
DOI
https://doi.org/10.1007/s12282-008-0038-z

Other articles of this Issue 4/2008

Breast Cancer 4/2008 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine